Substance P antagonists: novel agents in the treatment of depression

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.8, 2000-08, pp. : 1871-1875

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of Substance P Antagonists as Antiemetics

By Diemunsch P.

Drugs, Vol. 60, Iss. 3, 2000-09 ,pp. : 533-546

Adis International

Access to resources Recommend Favorite

Substance P receptor antagonists in the therapy of migraine

By May A. Goadsby P.J.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 673-678

Informa Healthcare

Access to resources Recommend Favorite

Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma

By Natarajan Nagendra Telang Sucheta Miller Donald Chesney Jason

Drugs, Vol. 71, Iss. 10, 2011-07 ,pp. : 1233-1250

Adis International

Access to resources Recommend Favorite

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders

By Oberman Lindsay M

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1819-1825

Informa Healthcare

Access to resources Recommend Favorite

Antagonists of IAP Proteins: Novel Anti-Tumor Agents

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-01 ,pp. : 3877-3892

Bentham Science Publishers

Access to resources Recommend Favorite